skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I am wondering what you think would have happened to the share price of Concordia had they NOT made the large acquisition of AMCo in September 2015. Do you think CXR would have been better off?

The acquisition of AMCo cost them US$3.5B, and the market liked it initially. They issued 8 million shares at US$65 to help pay for the acquisition. Yet the market cap of CXR is now only US$1.2B, much less than half of what they paid for AMCo, and the share price is now under US$24. Now they put themselves up for sale. Why would they do that?

I know they have been tainted by the problems in the healthcare sector like at VRX, and Hillary’s tweet, but still wasn’t it supposed to be a great acquisition for them, yet the stock has lost almost 75% of its value since then. Yes they have large debt, and that was known when they made the acquisition, and it didn’t seem to matter then. Now everyone cares about it, and the stock is under a short attack.

I want to be a believer in CXR, however, I like to understand what is going on, and at the moment I don’t get it. What lessons can a retail investor learn from this fiasco?

Paul
Read Answer Asked by Paul on June 23, 2016
Q: The share price continues to languish, although it is up substantially from its earlier lows (but still down from its highs). Despite this malaise, the stock continues to draw widespread support from several BNN analysts and others. Why is the proposed restructuring not better reflected in share price? Does it suggest there is a greater deal of risk in this happening than first thought or that restructuring will not prove to be that beneficial?

Appreciate your insight?

Paul F.
Read Answer Asked by Paul on June 23, 2016
Q: Any comments on the deal announced today with HP?

As a secondary question, when deals that have long closing dates (this is scheduled to close in 2017, I beleive) when should we expect the share price to react? Of course it depends on the deal but is there normally an immediate change, followed by more activity towards the closing date or does it all tend to get baked in right away?

Appreciate your insight.

Paul F.
Read Answer Asked by Paul on June 21, 2016
Q: Hi, Sylogist continues to buy back its stock significantly under new NCIB, most recent being 99,700 shares for $9.99 on June 17. I know it's a solid vote of company's confidence in its own stock being undervalued. So, is it a good strategy to add to my position alongside the company at current levels $10. My second question is if Sylogist prefers using its cash chest to buy its own stock, does it indicate that new acquisitions are not near the horizon ? Thanks
Read Answer Asked by rajeev on June 20, 2016
Q: First bought a small position when it had dropped to $90 from its alt-time of around $117. Averaged down several months ago to a $53 cost and about a 3.5% position. Am thinking about chasing it at its current price of $29 to lower my cost to $40. Can't understand the downward pressure on this stock. I know it has some debt but also strong earnings. Can't help but think of Teck when it was down below $4 not that long ago and now is over $15. I don't like averaging down but it just seems so mis-priced. Forgetting about the short manipulations, do you you see any faundamental downside risk.




Read Answer Asked by Lloyd on June 20, 2016
Q: Hello team,
thank you for your all your investments answers and for the ones regarding Concordia Healthcare in particular.
Going forward it seems that unfortunately the sentiment towards Biotech stocks, Brexit, the similarities with Valeant, short attacks and other possible concerns with CXR is simply killing the share price and CXR has become a falling knife...

In addition technically speaking it just broke below 2016 lows... Do you still think its buyable now?

Thx again!
Read Answer Asked by Michel on June 16, 2016
Q: Hello, I am wondering where you guys can put the floor price for that stock (where is become so cheap that big investors will buy the stock) considering the fact that it seems that there is no institutional appetite for that stock even if it is falling like a rock and become cheaper...

The apparent "cheap" valuation of the company at this point does not seem to attract any big players and even if I believe in the company's potential.

I am scratching my head due to the fact that there is actually mostly short sellers attracted to the stock and as the share price keep falling, the company seems less and less it seems to me that the company lost control of its own destiny.
Read Answer Asked by Michel on June 15, 2016
Q: Hello 5i team,

I'm currently building a portfolio from scratch for my mother who is 61 and retired. We are thinging conservative value and income equities for 10+ years.

Which 5 stocks, either from your balanced or income portfolio would you use as building blocks? If possible, can you recommend stocks that are fairly priced at the moment?

Thank you for your excellent service,

Cam.
Read Answer Asked by Cameron on June 10, 2016